628 antibodies registered
Antibody ID ∧ ∨ | Antibody name ∧ ∨ | Epitope ID ∧ ∨ | Epitope name ∧ ∨ | Recognition region ∧ ∨ |
---|---|---|---|---|
AN0100 | G159 | EP0017 | Cyclic Sialyl 6-Sulfo Lewis x | cyclicNeu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)[HSO3(-6)]GlcNAc-R |
AN0152 | CS-56 | EP0083 | Chondroitin-6-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
AN0143 | MC21C | EP0083 | Chondroitin-6-Sulfate | -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
AN0776 | MK-302 / MK302 | EP0083 | Chondroitin-6-Sulfate | -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
AN0141 | 2H6 | EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
AN0530 | BE-123 | EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
AN0152 | CS-56 | EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- -{GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
AN0142 | LY111 | EP0082 | Chondroitin-4-Sulfate | -{GlcA(b1-3)[HSO3(-4)]GalNAc(b1-4)}n- |
AN0144 | 473A12 | EP0081 | Chondroitin | -[GlcA(b1-3)GalNAc(b1-4)]n- |
AN0138 | MO-225 | EP0084 | Chindroitin Sulfate D Unit | -{[HSO3(-2)]GlcA(b1-3)[HSO3(-6)]GalNAc(b1-4)}n- |
AN0214 | A2B5 | EP0033 | C-Series Gangliosides Oligosaccharide / Gangliotetraosyl Core Structure | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R Neu5Ac9Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R |
AN0440 | M6703 | EP0033 | C-Series Gangliosides Oligosaccharide / Gangliotetraosyl Core Structure | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)-R |
AN0441 | M6704 | EP0033 | C-Series Gangliosides Oligosaccharide / Gangliotetraosyl Core Structure | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)-R |
AN0442 | M7103 | EP0033 | C-Series Gangliosides Oligosaccharide / Gangliotetraosyl Core Structure | R-Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
AN0295 | Q211 | EP0033 | C-Series Gangliosides Oligosaccharide / Gangliotetraosyl Core Structure | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R |
AN0214 | A2B5 | EP0032 | C-Series Gangliosides Oligosaccharide / Hemato- or Ganglio-Type | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R Neu5Ac9Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)Gal-R |
AN0440 | M6703 | EP0032 | C-Series Gangliosides Oligosaccharide / Hemato- or Ganglio-Type | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)-R |
AN0441 | M6704 | EP0032 | C-Series Gangliosides Oligosaccharide / Hemato- or Ganglio-Type | Neu5Ac(a2-8)Neu5Ac(a2-8)Neu5Ac(a2-3)-R |
AN0221 | 1E3 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0222 | 3H1 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0478 | MBr1 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0221 | 1E3 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0222 | 3H1 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0478 | MBr1 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0531 | 0.BG.5 | EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R |